Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 7—July 2007

Virulence Characteristics of Klebsiella and Clinical Manifestations of K. pneumoniae Bloodstream Infections

Victor L. Yu*Comments to Author , Dennis S. Hansen†, Wen Chien Ko‡, Asia Sagnimeni*, Keith P. Klugman§, Herman Goossens#, Marilyn M. Wagener*, Vicente J. Benedi**1, Meningeal Disease Surveillance in South Africa¶, and the International Klebsiella Study Group

Author affiliations: *University of Pittsburgh, Pittsburgh, Pennsylvania, USA; †Statens Serum Institut, Copenhagen, Denmark; ‡National Cheng Kung University Medical College, Tainan, Taiwan, Republic of China; §Emory University, Atlanta, Georgia, USA; ¶South African Institute of Medical Research, Johannesburg, South Africa; #University Hospital, Antwerp, Belgium; **Universidad de las Islas Baleares, Palma de Mallorca, Spain;

Main Article

Table 3

Underlying disease and virulence factors in community-acquired K. pneumoniae pneumonia*

Country/condition K1 or K2 
serotype, % Mucoid 
phenotype, % Aerobactin production, % Mouse 
mortality rate, %†
South Africa 50 (12/24) 75 (18/24) 67 (16/24) 58
No underlying disease 63 (12/19) 89 (17/19) 79 (15/19) 78
Underlying disease‡ 0 (0/5) 20 (1/5) 20 (1/5) 0
Taiwan 48 (11/43) 65 (15/23) 57 (13/23) 35
No underlying disease 75 (9/12) 100 (12/12) 83 (10/12) 50
Underlying disease‡ 18 (2/11) 18 (2/11) 27 (3/11) 18

*Note that patients with no underlying disease were more likely to be infected by strains with the putative risk factors than were elderly patients or patients with serious underlying disease. See Results for p values.
†2 mice were tested for each available strain.
‡Underlying disease was defined as presence of end-stage liver or renal failure, metastatic malignancy, neutropenia, or age >70.

Main Article


2The International Klebsiella Study Group comprises the previously named authors plus Jose Maria Casellas, Gordon Trenholme, Joseph McCormack, Sunita Mohapatra, and Lutfiye Mulazimoglu.

Page created: June 21, 2010
Page updated: June 21, 2010
Page reviewed: June 21, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.